Sada Haruki, Hinoi Takao, Ueno Hideki, Yamaguchi Tatsuro, Inoue Yasuhiro, Konishi Tsuyoshi, Kobayashi Hirotoshi, Kanemitsu Yukihide, Ishida Fumio, Ishida Hideyuki, Tomita Naohiro, Matsubara Nagahide, Sugihara Kenichi
Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Department of Surgery, Institute for Clinical Research, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1, Aoyama-cho, Kure-shi, Hiroshima, 737-0023, Japan.
Surg Today. 2019 Jan;49(1):72-81. doi: 10.1007/s00595-018-1710-3. Epub 2018 Sep 4.
To investigate the recent Japanese prevalence of thyroid cancer and its characteristics in familial adenomatous polyposis (FAP) patients, through the development of surveillance programs.
The subjects of this study were 282 (93.1%) FAP patients for whom information on thyroid cancer was available, from among 303 patients registered in "the Retrospective Cohort Study of Familial Adenomatous Polyposis in Japan" database. We evaluated the prevalence and risk factors for thyroid cancer and integrated and/or compared our findings with those of previous reports, using a systematic review, including a meta-analysis.
Thyroid cancer was diagnosed in 16 women (11.4%) and 2 men (1.4%), at 17-41 years and 39-57 years of age, respectively. The prevalence of thyroid cancer was 6.4%, with a female-to-male ratio of 8:1, which is comparable to reports from other countries. A young age of < 33 years at the FAP diagnosis and female gender were identified as independent risk factors for thyroid cancer.
FAP-associated thyroid cancer predominantly affects young women, both in Japan and other countries. Since FAP is generally diagnosed when patients are in their 20 s or older, regular screening for thyroid cancer is recommended for all FAP patients, but especially women, from their early 20 s.
通过制定监测计划,调查日本近期家族性腺瘤性息肉病(FAP)患者中甲状腺癌的患病率及其特征。
本研究的对象是“日本家族性腺瘤性息肉病回顾性队列研究”数据库中登记的303例患者中的282例(93.1%)有甲状腺癌信息的FAP患者。我们评估了甲状腺癌的患病率和危险因素,并通过系统评价(包括荟萃分析)将我们的研究结果与既往报告的结果进行整合和/或比较。
分别在17 - 41岁和39 - 57岁的16名女性(11.4%)和2名男性(1.4%)中诊断出甲状腺癌。甲状腺癌的患病率为6.4%,女性与男性的比例为8:1,这与其他国家的报告相当。FAP诊断时年龄小于33岁和女性被确定为甲状腺癌的独立危险因素。
在日本和其他国家,FAP相关的甲状腺癌主要影响年轻女性。由于FAP通常在患者20多岁或更年长时被诊断出来,因此建议对所有FAP患者,尤其是20岁出头的女性,进行定期甲状腺癌筛查。